![Ben Schwartz Profile](https://pbs.twimg.com/profile_images/1383497323309780994/U2jyBwtX_x96.jpg)
Ben Schwartz
@BSchwartzMD
Followers
78
Following
107
Statuses
35
Rush GI and Hepatology Fellow | Duke Undergrad | VCU SOM | Rush IM | Clinical Liver Disease Social Media Rep
Joined April 2021
RT @NancyReau: ⚕️We have an excellent agenda & an all-star lineup of experts for the #RushIntoGI conference in February! Take a peek 👉 http…
0
4
0
@luo_david @hopkinsheart @JochenReiser @avolgman @cardio10s @jssoble @3heretics @RUSHCardiology @RushMedical Incredible achievement David, very excited for you!
1
0
1
Having a blast at #ACG2022 with my @RushDOIM co-residents and fellows. Honored to receive an outstanding poster presentation award for my work with @JessStrzepkaMD. Can’t wait for #ddw2023 in Chicago! @RushIMChiefs @AmCollegeGastro @ManaviBhagwat @taviabuyssemd
0
1
17
RT @JessStrzepkaMD: Great first day at #ACG2022 enjoying the postgraduate course! @ManaviBhagwat @BSchwartzMD @TaviaBuysseMD @AmCollegeGast…
0
3
0
Do you incorporate telemedicine in your Hepatology practice? Telemedicine is susceptible to creating 'intervention-generated inequalities'. Read more on how to combat these liver health disparities: @CLD_Learning
#CLDSoMeReps
@Julius__Wilder
@NancyReau
0
2
4
RT @NancyReau: ⚡ Quick 1 min read: Perspective on the @US_FDA granting fast track status to ervogastat + clesacostat for #NASH 🔗 https://t…
0
2
0
Breaking down Hepatic Encephalopathy for patients and families can be a challenge. This is a great resource for them to better understand HE. @CLD_Learning
#CLDSoMeReps
@Julius__Wilder
@NancyReau
0
9
16
RT @NancyReau: Natural history and management of refractory autoimmune hepatitis @rushdoim @bschwartzmd @aasldtwe…
0
3
0
Do you recommend bariatric surgery for treatment of NASH fibrosis? A great overview of the current evidence supporting utilizing bariatric surgery as a key intervention in the fight against NASH @CLD_Learning
#CLDSoMeReps
@Julius__Wilder
@NancyReau
0
7
25
How should we approach end-of-life discussions with patients with advanced liver disease while maintaining cultural humility? A great article summarizing some initial approaches: @CLD_Learning
#CLDSoMeReps #CLDREP
@Julius__Wilder
@NancyReau
1
5
23
Had an incredible time meeting experts from across the globe and presenting my work on AIH/NAFLD overlap and PEG tube complications at #DDW2022 with the Rush GI crew. Excited for next year in Chicago! @NancyReau @DDWMeeting @RushMedical @RushIMChiefs
0
0
7
RT @JessStrzepkaMD: So much fun at my first DDW! Grateful for the opportunity to share my research and learn from leaders in the field. Loo…
0
2
0
Great article covering the multifactorial pathophysiology of HE: neuro-inflammation, alterted neurotransmission, bile acids, the microbiome, and nutrition all contribute in addition to ammonia @CLD_Learning #CLDSoMeReps @Julius__Wilder @NancyReau
0
2
6
Statins may slow liver disease progression and HCC. Here's a great overview of the preclinical/retrospective data. Ongoing clinical trials may give us more answers and help guide future treatment @CLD_Learning
#CLDSoMeReps
@Julius__Wilder
@NancyReau
0
1
1
Great review article covering socioeconomic disparities of travel for liver transplantation. Have we adequately evaluated the ethical considerations? @CLD_Learning
#CLDSoMeReps #CLDREP
@Julius__Wilder @NancyReau
0
2
5
An excellent overview of common GI drugs implicated in DILI by Rush's @KanikaGargMD
@CLD_Learning
#CLDSoMeReps #CLDREP
0
2
2
HCC surveillance with ultrasound combined with AFP improve sensitivity of detecting early HCC. In the future, MRI and additional protein & genomic biomarkers may hold the key to further improving detection @CLD_Learning #CLDREP @docamitgs @PiyushNathani3
0
4
18